Acacia Subsidiary Acquires Rights to Orthopedic Technology Patents

by Benzinga Staff
December 27, 2012 6:05 AM | 15 seconds read

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

Acacia Research Corporation (NASDAQ: ACTG) announced today that a subsidiary has acquired rights to patents in the orthopedic technology sector. “Acacia continues to increase the number of patent portfolios we control in the medical device and diagnostics sectors,” commented Paul Ryan, CEO. See full press release

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsGuidanceManagementGlobal

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.